Ovarian Brenner Tumor Clinical Trials

Completed

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00888615

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +39 more
Locations: Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States

John Muir Medical Center-Concord Campus Concord, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

University of California San Diego San Diego, California, United States

View all 163 locations

View Trial Details

Completed

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00989651

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +59 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of Colorado Hospital Aurora, Colorado, United States

Augusta University Medical Center Augusta, Georgia, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View all 23 locations

View Trial Details

Completed

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +41 more
Locations: Hartford Hospital Hartford, Connecticut, United States

The Hospital of Central Connecticut New Britain, Connecticut, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Washington University School of Medicine St Louis, Missouri, United States

View all 14 locations

View Trial Details

Completed

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00262847

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +48 more
Locations: Northeast Alabama Regional Medical Center Anniston, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Clearview Cancer Institute Huntsville, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

View all 632 locations

View Trial Details

Completed

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00939809

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations: Georgia Regents University Medical Center Augusta, Georgia, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Nebraska Methodist Hospital Omaha, Nebraska, United States

Stony Brook University Medical Center Stony Brook, New York, United States

View all 16 locations

View Trial Details

Completed

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

NCT01080521

Conditions: Adnexal Diseases, Brenner Tumor, Cognitive Side Effects of Cancer Therapy, +79 more
Locations: University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States

Roy and Patricia Disney Family Cancer Center Burbank, California, United States

View all 182 locations

View Trial Details

Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

NCT00897442

Conditions: Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
Locations: Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States

Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States

View all 187 locations

View Trial Details

Completed

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

NCT00060359

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +32 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086

Conditions: Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Cooper Hospital University Medical Center Camden, New Jersey, United States

Riverside Methodist Hospital Columbus, Ohio, United States

View Trial Details

Completed

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

NCT01294293

Conditions: Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations: Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States

Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States

University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

View Trial Details

Ovarian Brenner Tumor

Ovarian Brenner Tumor trial results

Related conditions